Gould Capital’s Xperi XPER Stock Holding History

Gould Capital’s Portfolio XPER Stock Details XPER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20	Closed	-$172	–	208
2022 Q4	$172	Buy	+20	New	+$229	﹤0.01%	201

Other funds holding XPER

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Gould Capital's XPER Position: Q1 2023 in Review

Gould Capital sold out of Xperi (XPER) in Q1 2023, closing a stake of 20 shares — an estimated $172 sold.

Gould Capital first reported a position in XPER in Q4 2022 and held it in 1 quarter. The position peaked at $172 in Q4 2022. 159 funds tracked by Wall St. Rank hold XPER as of Q1 2023.

Gould Capital reported no remaining Xperi position as of Q1 2023 after selling out during the quarter.
Gould Capital sold 20 Xperi shares in Q1 2023, an estimated $172.
Gould Capital first reported a position in Xperi in Q4 2022 and held it in 1 quarter.
Gould Capital's Xperi position peaked at $172 in Q4 2022.
159 funds tracked by Wall St. Rank held Xperi as of Q1 2023.

Based on Gould Capital's 13F filing for Q1 2023, filed 16 May 2023.